Effect on Weight Loss of Exenatide Versus Placebo
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- James Malone, MD
Eli Lilly and Company
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Peoria, Arizona, United States
- Research Site
Jacksonville, Florida, United States
- Research Site
Orlando, Florida, United States
- Research Site
Indianapolis, Indiana, United States
- Research Site
Boston, Massachusetts, United States
- Research Site
Minneapolis, Minnesota, United States
- Research Site
St Louis, Missouri, United States
- Research Site
Spartanburg, South Carolina, United States
- Research Site
San Antonio, Texas, United States
- Research Site
Renton, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2006
- Primary completion
- 29 Feb 2008
- Completion
- 29 Feb 2008
- Last update posted
- 7 Apr 2015
- Registered enrollment
- 196
- Registry id
- NCT00375492
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.